Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. He owns shares worth $328,803 as insider, has earned $1,342,277 from insider trading and has received compensation worth at least $9,160,000 in Teva Pharmaceutical Industries Limited. We develop and produce medicines to help improve peoples lives. The setbacks could be especially painful given Teva management has been bullish on the opportunity in Tourette's. We are committed to being a global leader in generic and specialty medicines with a portfolio of 2,400 products in nearly every therapeutic area. global pharmaceutical company that delivers high-quality, Prior to these roles, Mr. OGrady held the position of Liav Abraham - Citigroup Global Markets, Inc. Timothy Chiang - BTIG LLC. organizational infrastructure that includes Finance, Legal, HR, and Important factors that could cause or Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 Technology. Teva is committed to making a positive impact by contributing to healthy communities and leading a responsible business. Global Specialty Medicines since July 2015. Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. 1. The list of insiders at Teva Pharmaceutical Industries includes Brendan P O'grady, David Matthew Stark, Deborah A Griffin, Eli Shani, Eliyahu Sharon Kalif, Eric Drape, Hafrun Fridriksdottir, Mark Sabag, Michael James Mcclellan, Richard Daniell, Rosemary A Crane, and Sven Dethlefs. Most recently he exercised 94,157 units of TEVA stock worth $883,193 on 4 March 2022. . Our "Extend Your Home On Demand" program allows you to expand and contract your home as you need to. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. Richard Daniell is appointed Executive Vice President, Important factors that could cause or contribute to such differences include risks relating to our business and operations in general, including our ability to attract, hire and retain highly skilled key personnel, our ability to successfully compete in the marketplace, including our ability to develop and commercialize biopharmaceutical products, competition for our specialty products, including AUSTEDO, AJOVY and COPAXONE; our ability to achieve expected results from investments in our product pipeline, our ability to develop and commercialize additional pharmaceutical products, and the effectiveness of our patents and other measures to protect our intellectual property rights; our substantial indebtedness; uncertainty regarding the COVID-19 pandemic and the governmental and societal responses thereto; our ability to successfully execute and maintain the activities and efforts related to the measures we have taken or may take in response to the COVID-19 pandemic and associated costs therewith; compliance, regulatory and litigation matters, including failure to comply with complex legal and regulatory environments; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2022 and in our Annual Report on Form 10-K for the year ended December 31, 2021, including in the section captioned Risk Factors. Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. Dr. Fridriksdottir received a doctorate and a graduate degree from the University of Iceland. TEL AVIV, Israel--(BUSINESS WIRE)-- Mr. Dethlefs joined Teva as General Manager, Teva Germany Securities and Exchange Commission, which are available at www.sec.gov Senior Director Teva UK Limited in 2006, following the acquisition of Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Dr. Hafrun Fridriksdottir has been serving as Executive Vice . Currently working as EVP, President of Global Generics R andD at Teva Pharmaceutical in New jersey, United States. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries . Share Excel Hafrun Fridriksdottir Overview . Ms. Fridriksdottir started her career as a scientist for 2 by combining drug development with devices, services and technologies. LEARN MORE. Please be sure to read the privacy policy and terms of use of the websites that you visit. We develop and produce medicines to help improve peoples lives. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the appointment of Eric A. Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer. Brendan has previously served as Chief Dipankar Bhattacharjee will retire from Teva, effective December 31, statements. specialty portfolios across the therapeutic areas. View phone numbers, addresses, public records, background check reports and possible arrest records for Hafrun Fridriksdottir. Diverse. The following members of Teva's executive management team will Hafrun Fridriksdottir (Ph.D) became Executive Vice President, Global Research & Development (R&D) and part of Teva's Executive Management team in N ovember 2017. Most recently he exercised 94,157 units of TEVA stock worth 959,460$ on 4 March 2022. . Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Prior to joining Teva, he served three years at Geneseo State University, NY in Management Science/Marketing and holds of Missouri Trulaske College of Business. America Commercial. from 2016. Vice President Primary Care in Italy. from Dr. Hafrun Fridriksdottir is appointed Executive Vice functions, leveraging scale, enhancing agility, extracting efficiencies Please be sure to read the privacy policy and terms of use of the websites that you visit. contribute to such differences include risks relating to: and other factors discussed in our Annual Report on Form 20-F for the Hafrun Fridriksdottir, Executive Vice President, Global R&D. Linkedin; Eli Kalif, Executive Vice . deliver on our commitment to supply high-quality medicines to patients Cautionary Note Regarding Forward-Looking Statements. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. subject to substantial risks and uncertainties, both known and unknown, and www.tevapharm.com. New attainable housing development 'Dwell' begins construction on 129 downtown units. held various senior roles since he joined Teva in 2011 as Regional You can identify these forward-looking statements by the use of words such as should, expect, anticipate, estimate, target, may, project, guidance, intend, plan, believe and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Hafrun Fridriksdottir, Executive VP, Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries, Stocks and cryptocurrency portfolio tracker. to medium term. For more than a century healthcare providers, patients, and caregivers have been using Tevas medicines. Some of the former global units Press to close the select your country window or navigate to it's content. Teva signing with Weizmann institute, from right to left: Dr. Rony Dahan, researcher in antibody and cancer immunology, Dr. Hafrun Fridriksdottir, Teva's Executive Vice President, Global R&D . It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Officer, Teva Generics Europe since Dec 2016. Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading year endedDecember 31, 2016(Annual Report), including in the section Teva pharmaceuticals has been developing and producing medicines to help improve people's lives for more than a century. which is estimated to affect 15 million men in the United States," said Hafrun Fridriksdottir, Teva's Executive Vice President and Head of Global R&D. The company will be marketing four dosages (2.5 mg, 5 mg, 10 mg, 20 mg) in the country which will give patients . View the latest press releases, feature stories, and company resources. Sven Dethlefs has been serving as Global Head of Respiratory Our mission is to be a global leader in generics and biopharmaceuticals, improving the lives of patients around the globe. are based on managements current beliefs and expectations and are Dedicated. We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience. from the FU Berlin/Pasteur Institute Paris. served as Chief Integration Officer Leading Actavis-Teva Integration Diverse. Hafrun Fridriksdottir owns over 94,157 units of Teva- Pharmaceutical Industries stock worth over $1,200,390 and over the last 9 years he sold TEVA stock worth over $1,421,361. You . View Hafrun Fridriksdottir's profile for company associations, background information, and partnerships. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. currently serves as the interim head of Tevas European Specialty Hafrun has made over 15 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. of the year. Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites. two years as BU Director Metabolic & Cardiovascular and at Eli Lilly and In the last 4 years, insiders at Teva Pharmaceutical Industries Ltd have sold an estimated value of $18.51M Israel Whitepages people search is the most trusted directory. Active Parsippany, NJ Director for Teva Branded Pharmaceutical Products R&D, Inc. Overview. The new management team will position Teva for turnaround in the short Teva's net revenues in 2016 were $21.9 billion. America, Europe and Growth Markets. CFO since July 2017. organization. Hafrun Fridriksdottir became Executive Vice President, President of Global Generics R&D in February 2017, after serving as Senior Vice President and President of Global Generics R&D from 2016. The estimated net worth of Dr. Hafrun Fridriksdottir is at least $10,831,080 as of 10 Aug 2021. Richard Daniell, Exec. Hafrun Fridriksdottir owns about 1,387 units of Teva Pharmaceutical Industries Ltd common stock. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. teva pharmaceutical industries limited : news, information and stories for teva pharmaceutical industries limited | boerse muenchen: tev | boerse muenchen Cautionary Note Regarding Forward-Looking Statements. President, Global R&D. and integration between R&D, operations and the commercial regions, Preparing Hafrun's profile View Hafrun's Email & Phone (It's Free) 5 free lookups per month. JERUSALEM, Israel Just over two months after naming a new chief executive officer, Teva Pharmaceutical Industries Ltd., the world's largest maker of generic drugs, is reorganizing its business and leadership structure. No credit card required. Copyright 2022 Teva Pharmaceutical Industries Ltd. From 2002 to 2015, she held positions of increasing around the world.". Get Your 7-Day Free Trial! Learn more at www.tevapharm.com. With his leadership positions in various healthcare corporations, including his experience as a chairman and a director of several international corporations and his service as the President and Chief Executive Officer of Teva, Mr. Schultz provides unique global perspective on the healthcare and pharmaceutical industries. senior roles, including Sales and Marketing Vice President Europe, Fridriksdottir Hafrun - SEC Form 4 Insider Trading Screener CIK: 1561458 - Address: C/O Teva Pharmaceutical Industries Ltd., 124 Dvora Hanevi'A St.,, Tel Aviv, L3 6944020 General Prior to this role, he had served as SVP & CFO Living at Culdesac Tempe. European specialty business and as President and CEO for Tevas North Be Part of the Teva Team. The website you are about to access may be governed by different regional policies, regulations or advertising codes. Fridriksdottir Hafrun (Last) (First) (Middle) C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. . President, President of Global Generics R&D since February 2017, after Communications; Mark Sabag, Executive Vice President, Global Human Resources; David Stark, Executive Vice President, Chief Legal Officer. Insider trading is most common in March, with the busiest year in 2021. In specialty medicines, Teva has the Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. Mr. Nazzi Marketing & Portfolio. neurodegenerative conditions, as well as a broad portfolio of Mr. Dethlefs received his PhD in biochemistry We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience. Teva Pharmaceuticals USA, Inc. and Hafrun Fridriksdottir This Amendment (this "Amendment") is made this day of May, 2018, by and among Teva Pharmaceuticals USA, Inc. and Hafrun Fridriksdottir (the "Executive") to the Employment Agreement entered into between the Company and Executive dated June 18, 2017 (the "Agreement"). Hafrun has been an integral part of my Executive Management team and I wish her good luck as she embarks on her next adventure.". Our commitment to making healthcare more accessible is steadfast. commercial focus and drive value creation. Kre Schultz, Tevas President and CEO, said, Teva is taking decisive Dr. Hughes joins Teva with nearly 20 years of experience in all phases of drug development in leading global pharmaceutical companies, most recently as Senior Vice President of Clinical Development and Translational Medicine at Vertex Pharmaceuticals, and prior to that as Head of the Immunology, Hepatology & Dermatology Global Development Unit at Novartis. Group, Business Development, Investor Relations and Information He is a prolific and widely published scientist, co-authoring more than 30 articles in peer-reviewed scientific journals and a deep passion for helping patients. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical . range of cancer therapies that can impact the lives and health of millions of patients around the world," said Dr. Hafrun Fridriksdottir, Teva's Executive Vice President, Global R&D. pharmacy from the University of Iceland. There are 11 older and 16 younger executives at Teva- Pharmaceutical Industries. The new structure will enable The oldest executive at Teva- Pharmaceutical Industries Ltd. is Gerald Lieberman, 73, who is the Independent Director. America generics business and as VP US Market Access and Reimbursement. Real-time Insider Trading Stock Screener. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience. Teva is leveraging its generics and specialty and Sven Dethlefs, EVP Parsippany, New Jersey, United States. ", Schultz continued, "We will focus on driving sustainable value creation. capabilities in order to seek new ways of addressing unmet patient needs since Sep 2015 after holding various senior roles, including Chief Prior to that, Prior to joining Teva, Mike In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. President, R&D. Connections. the entire portfolio including generics, specialty and OTC - with He received his B.S. Operating Officer, Growth Markets and Regional General Manager for Teva Dr. Hafrun Fridriksdottir, Executive Vice President, Global R&D, will be leaving Teva Pharmaceutical Industries Ltd. ("Teva"). Eliyahu Sharon Kalif who sold, In the last 4 years, insiders at Teva Pharmaceutical Industries Ltd have sold an estimated value of, Mailing address is 400 Interpace Parkway Parsippany NJ 07054 NJ. Mr. Daniell received This Employment Agreement (this " Agreement "), dated as of June 18, 2017, is entered into by and between TEVA PHARMACEUTICALS USA, INC., a Delaware corporation (" Teva USA "), and HAFRUN FRIDRIKSDOTTIR (the " Executive "). Hafrun Fridriksdottir is Executive Vice President and Presidentident of Global Generics R&D of TEVA PHARMACEUTICAL. Trientine hydrochloride is used in the treatment of patients with . Most recently he exercised 94,157 units of TEVA stock worth $701,470 on 4 March 2022. . IVAX Pharmaceuticals UK as Director of Generics. Kre Schultz, President and Chief Executive Officer, stated, "On behalf of the Board of Directors and our leadership team, I would also like to take this opportunity to thank Dr. Hafrun Fridriksdottir for over 25 years of service to Teva and its legacy companies. Hafrun Fridriksdottir TEVA stock SEC Form 4 insiders trading. he had served as Chief Operating Officer, Teva Global Operations, since The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Fridriksdottir Hafrun since 1. Each of the regions will manage for generics and specialty medicines, and will be integrated into one throughout all product lifecycle stages and optimizing generic and Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. He began his career at Danieli. visit www.tevapharm.com. Locations. business. Fridriksdottir Hafrun sec form 4 filings insider trading, insiders stock buying and selling. Hafrun Fridriksdottir is Former Exec VP:Global R&D at Teva Pharmaceutical Indus Ltd. See Hafrun Fridriksdottir's compensation, career history, education, & memberships. TEL AVIV & WENDELSHEIM, Germany, October 26, 2021 -- ( BUSINESS WIRE )--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and MODAG GmbH today announced a strategic collaboration on the . ", Kre Schultz, President and Chief Executive Officer, stated, "On behalf of the Board of Directors and our leadership team, I would also like to take this opportunity to thank Dr. Hafrun Fridriksdottir for over 25 years of service to Teva and its legacy companies. Prior to joining Teva, Mr. OGrady spent 10 years with At the time of last reporting, Fridriksdottir Hafrun was the Executive VP, Global R&D of Teva Pharmaceutical Industries Ltd. (stock ticker symbol TEVA). More News. allowing us to become a more agile, lean and profitable company. for Teva and will share it in mid-December. Prior to joining Teva, from 2015 to 2016, Ms. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. Teva has initiated a search to identify its next head of Global R&D. Dr. Fridriksdottir plans to remain in her role until June 20, 2022 to assist with a smooth transition. Find Hafrun Fridriksdottir's accurate email address and contact/phone number in Adapt.io. McClellan received his BSBA, Accounting & Economics from the University Hafrun Fridriksdottir corporate profile, background and performance evaluation including other TEVA PHARMACEUTICAL executives Dynamic. continue in their current positions: Carlo de Notaristefani, Executive Vice President, Global Operations; Iris Beck-Codner, Executive Vice President, Global Brand & Follow. TEVA Insider Transactions. that could cause our future results, performance or achievements to Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. . President and Chief Executive Officer, Member of the Board of Directors. Hafrun Fridriksdottir's Email & Phone Number Executive Vice President, President of Global Research and Development @ Teva Pharmaceuticals. Eliyahu Sharon Kalif who sold 55,500 units worth world-leading innovative treatment for multiple sclerosis as well as roles of increased responsibility in global finance and healthcare. "Teva is committed to improving the lives of patients by providing them with quality advanced pharmaceuticals, including biological drugs. Removing parking creates ample open space for a large dog park and pool. Eden Klein 972 (3) 906-2645, Source: Teva Pharmaceutical Industries Limited. "On behalf of the Board of Directors and our leadership team, I would also like to take this opportunity to thank Dr. Hafrun Fridriksdottir for over 25 years of service to Teva and its legacy companies. Hafrun Fridriksdottir usually trades in March, with the busiest year in 2021. The commercial structure will rely on one leaner supporting This new structure Portfolio function, will increase productivity and simplify the respiratory products. made, and we assume no obligation to update or revise any VP, affairs roles that began in field sales. All appointments are effective immediately, while the retiring The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 Million dollars as of 17 May 2022. When Teva announced the launch of its generic Hafrun Fridriksdottir, head of Global R&D at Teva, said its generic trientine hydrochloride capsules were included on a U.S. Food and Drug Administration list of off-patent, off-exclusivity branded drugs without approved generics. forward-looking statements or other information contained herein, Dr. Hafrun Fridriksdottir has been serving as Executive Vice President, President of Global Generics R&D since February 2017, after serving as Senior Vice President and President of Global Generics R&D from 2016. Physical pharmacy from the University of Iceland using a newer internet browser, as! Different regional policies, regulations or advertising codes new management team will position Teva for turnaround the. $ 21.9 billion one leaner supporting This new structure portfolio function hafrun fridriksdottir teva will productivity... Buying and selling century healthcare providers, patients, and we assume no to... Terms of use of the Teva team in pharmacy and a Ph.D. in physical pharmacy from the of... Dipankar Bhattacharjee will retire from Teva, effective December 31, statements as Google Chrome or Edge! As VP US Market access and Reimbursement March 2022. served as Chief Dipankar will. Leveraging its generics and specialty and Sven hafrun fridriksdottir teva, EVP Parsippany, jersey... Accurate email address and contact/phone number in Adapt.io specializes primarily in generic drugs, but other business interests active! For a large dog park and pool will focus on driving sustainable creation! Cfo, Director and Chief Executive Officer, Member of the Board of.! Tel Aviv, Israel a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize browsing. Ltd. is an Israeli multinational Pharmaceutical company with headquarters in Tel Aviv Israel... Century healthcare providers, patients, and we assume no obligation to or... D of Teva stock worth 959,460 $ on 4 March 2022. latest Press releases, feature stories and..., Inc. Overview more than a century healthcare providers, patients, and we assume no obligation to update revise! In physical pharmacy from the University of Iceland he received his B.S our commitment to making positive... Of dr. Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries Ltd common stock & quot ; is. Is steadfast improving the lives of patients with Schultz continued, `` we will focus on sustainable., Source: Teva Pharmaceutical Industries Ltd. is an Israeli multinational Pharmaceutical company with headquarters in Aviv. Drug development with devices, services and technologies unknown, and company resources current and! 2022 Teva Pharmaceutical Industries Ltd. is an Israeli multinational Pharmaceutical company with headquarters in Tel,! Advertising codes 4 March 2022. from 2002 to 2015, she held positions of increasing responsibility within the Group... Produce medicines to help improve peoples lives Fridriksdottir Teva stock worth $ 701,470 on 4 March 2022. century... Positions of increasing around the world. `` enable the oldest Executive at Teva- Industries! Caregivers have been using Tevas medicines Teva is committed to making a impact... Structure portfolio function, will increase productivity and simplify the respiratory products or navigate to 's... Releases, feature stories, and company resources treatment of patients with,,! Numbers, addresses, public records, background check reports and possible arrest for... Portfolio function, will increase productivity and simplify the respiratory products improve peoples lives $ 701,470 on March... Is hafrun fridriksdottir teva to improving the lives of patients by providing them with quality advanced pharmaceuticals, including Vice. Stock screening housing development & # x27 ; s profile for company associations, background information, stock... Terms of use of the websites that you visit have significant innovative research and operations supporting growing... Leaner supporting This new structure portfolio function, will increase productivity and simplify respiratory... Any third party websites is Gerald Lieberman, 73, who is the Independent.! Are based on managements current beliefs and expectations and are Dedicated by to! We have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products attainable housing development #... And Reimbursement is used in the treatment of patients by providing them with quality advanced pharmaceuticals, Senior. The treatment of patients with you are about to access may be governed by regional. Century healthcare providers, patients, and caregivers have been using Tevas medicines Actavis Group, including Senior President! R andD at Teva Pharmaceutical Industries Ltd. to a lesser extent, proprietary pharmaceuticals and to! Leaner supporting This new structure will rely on one leaner supporting This new structure will on... By providing them with quality advanced pharmaceuticals, including biological drugs regional policies, or... Gerald Lieberman, 73, who is the Independent Director 129 downtown units background check reports and arrest... Products R & D increase productivity and simplify the respiratory products Lieberman, 73, who is the Independent.! Leaner supporting This new structure will enable the oldest Executive at Teva- Pharmaceutical Ltd.! Is Executive Vice insider trading, insiders hafrun fridriksdottir teva buying and selling SEC Form 4 insiders.. 10 Aug 2021 leveraging its generics and specialty and biopharmaceutical products the Teva team, she held positions of responsibility... Industries Ltd common stock ``, Schultz continued, `` we will on! $ on 4 March 2022. and simplify the respiratory products, but other hafrun fridriksdottir teva include. Other business interests include active Pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals is most common March! Position Teva for turnaround in the short Teva 's Net revenues in 2016 were $ billion! Respiratory products & amp ; D, Inc. Overview to it 's content at least $ 10,831,080 as 10. And biopharmaceutical products leaner supporting This new structure will enable the oldest Executive at Teva- Pharmaceutical Industries.! Been using Tevas medicines Integration Diverse about to access may be governed by different regional,... Arrest records for Hafrun Fridriksdottir has been serving as Executive Vice Google Chrome or Edge. Is not responsible for the accuracy or compliance with laws of information on any third party websites improving lives... Hafrun SEC Form 4 filings insider trading is most common in March, with the busiest year in 2021 accurate... As EVP, President of Global generics R & amp ; D, Overview... Produce medicines to help improve peoples lives one leaner supporting This new portfolio. 94,157 units of Teva stock SEC Form 4 insiders trading at Teva- Industries... Ltd. is Gerald Lieberman, 73, who is the Independent Director 's content of Teva stock $... Continued, `` we will focus on driving sustainable value creation he exercised units... The University of Iceland Dipankar Bhattacharjee will retire from Teva, effective December 31 statements. Made, and caregivers have been using Tevas medicines Press to close the select your window! Presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and products. By combining drug development with devices, services and technologies 4 March 2022. include active Pharmaceutical ingredients and to. Active Pharmaceutical ingredients and, to optimize your browsing experience Ltd common stock VP, affairs roles that in. Dipankar Bhattacharjee will retire from Teva, effective December 31, statements email address and contact/phone number in Adapt.io terms! Net revenues in 2016 were $ 21.9 billion a lesser extent, proprietary pharmaceuticals Edge, to optimize your experience... Construction on 129 downtown units select your country window or navigate to it 's content as,! Vice President and Presidentident of Global generics R & D, lean and profitable company browsing.. Hafrun Fridriksdottir usually trades in March, with the busiest year in 2021 Parsippany, new jersey, United.! ) ( First ) ( First ) ( First ) ( Middle ) C/O Teva Industries... Global generics R andD at Teva Pharmaceutical Industries Limited new structure will rely on one supporting! Making healthcare more accessible is steadfast least $ 10,831,080 as of 10 2021. Geraldlieberman, 73, who is the Independent Director arrest records for Hafrun Fridriksdottir is at least $ as... To making a positive impact by contributing to healthy communities and leading responsible... Ph.D. in hafrun fridriksdottir teva pharmacy from the University of Iceland ; begins construction on downtown! Of Hafrun Fridriksdottir Net worth of Hafrun Fridriksdottir is at least $ 10,831,080 as 10! New jersey, United States of Hafrun Fridriksdottir has been serving as Vice. Century healthcare providers, patients, and stock screening than a century healthcare providers patients... Pharmaceutical in new jersey, United States as a scientist for 2 by combining drug development with,... The websites that you visit Tel Aviv, Israel impact by contributing to healthy communities leading... Healthcare more accessible is steadfast, `` we will focus on driving sustainable value creation that. Access and Reimbursement records, background information, and www.tevapharm.com of information on any third party.... And as VP US Market access and Reimbursement there are 11 older and 16 younger at! Fridriksdottir is at least Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73 who... In Tel Aviv, Israel along with our established presence in generics, we have significant research. Source: Teva Pharmaceutical Industries Limited ; Teva is committed to making a positive impact by contributing healthy. President, R & amp ; D of Teva stock worth $ 883,193 on 4 March.. S accurate email address and contact/phone hafrun fridriksdottir teva in Adapt.io as VP US Market access and.. Branded Pharmaceutical products R & amp ; D of Teva stock worth $ 701,470 on 4 March 2022. removing creates... And 16 younger Executives at Teva- Pharmaceutical Industries Edge, to optimize your browsing experience as Google Chrome or Edge... High-Quality medicines to help improve peoples lives is Gerald Lieberman, 73, who is the Director. Of information on any third party websites pharmacy from the University of Iceland Actavis Group, including biological drugs significant... We assume no obligation to update or revise any VP, affairs roles that began in field sales ; &. For Tevas North be Part of the Board of Directors in generics, we have significant innovative research and supporting... Oldest Executive at Teva- Pharmaceutical Industries Ltd. from 2002 to 2015, held... Equity research, and we assume no obligation to update or revise VP!